Klencke Barbara 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Klencke Barbara
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
[F1]2026-03-03+700,000→ 700,000 totalExercise: $2.07Exp: 2036-03-02→ Common Stock (700,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter.
Signature
/s/ Shelly Pinto, by power of attorney|2026-03-05